CME Outfitters

01/19/2026

🧠 Ready to bring new tools to your neurology practice?
This free CME activity dives into the clinical use of FcRn antagonists for patients with gMG, helping you optimize care in a multidisciplinary setting.

📺 Watch now: https://cmeo.me/WCV-097

✔ MOA deep dive
✔ Patient selection strategies
✔ Real-world treatment planning

Generalized myasthenia gravis (gMG) is a chronic neuromuscular disorder that results from destruction of the neuromuscular junction by pathogenic autoantibodies, partially through the actions of the neonatal Fc receptor (FcRn). Traditional therapies only partially alleviate the...

01/18/2026

🙌 Thank you for participating in our on-demand activity:
Ditch the Guesswork: Non-Invasive Tools That Slay Diagnosis and Monitoring

Help extend the impact—share this activity with your colleagues today! 👥📣
👉 View the activity: https://cmeo.me/SN-284

Apply these practical takeaways to strengthen MASLD/MASH care in your practice:

🔹 Increase screening for MASLD/MASH among patients with type 2 diabetes and other risk factors
🔹 Use non-invasive tests (NITs) to stratify risk—and identify which options are available in-house, through local labs, or via referral
🔹 Leverage appropriate NITs to monitor disease progression over time

These steps can help reduce diagnostic uncertainty and support more confident, evidence-based management. 💙

Building on the patient case introduced in Part 1, this CME Outfitters Snack takes learners through the next steps in evaluating Mr. B, a patient with relatively normal liver function tests but an indeterminate Fibrosis-4 (FIB-4)...

01/18/2026

🧠 Obesity is a chronic, progressive disease—not a personal failure.

This education program helps clinicians reframe obesity care using current evidence and clinical guidelines.
🔗 https://cmeo.me/CN-051

Obesity affects more than 44% of post-9/11 U.S. Veterans—far surpassing rates in the general population—and contributes substantially to cardiometabolic disease, osteoarthritis, chronic pain, sleep apnea, and type 2 diabetes. Despite strong evidence supporting effective treatments, clinical...

01/17/2026

🙌 Thank you for participating in our activity:
Step Into Prevention: Mastering the Power of PrEP in HIV Care

Help extend the impact—share this on-demand archive with your colleagues today! 👥📣
👉 View the activity: https://cmeo.me/MMV-156

Consider applying these goals in your practice to strengthen HIV prevention efforts:

🔹 Increase routine HIV testing using a status-neutral approach across care settings
🔹 Counsel patients on the full range of PrEP options, including oral and long-acting injectable (LAI) formulations
🔹 Expand shared decision-making conversations that address stigma, side-effect concerns, and wellness framing
🔹 Improve PrEP assessment and culturally sensitive counseling for adolescents and underserved populations

Together, these steps can help advance equitable, patient-centered HIV prevention. 💙

Pre-exposure prophylaxis (PrEP) is an established and highly effective method of preventing sexually transmitted human immunodeficiency virus (HIV) infections and has been instrumental in declining incidence rates. Adherence and access to HIV prevention still pose challenges...

01/17/2026

🧩 Ready to crack the code in PBC care?
Step into an immersive virtual escape room designed to sharpen diagnosis and treatment skills for primary biliary cholangitis.
🔗 https://cmeo.me/IN-013

Embark on a one-of-a-kind learning adventure designed to sharpen your diagnostic skills and treatment prowess for primary biliary cholangitis (PBC). In this immersive virtual escape room, you’ll tackle patient case challenges, uncover hidden clues, and piece...

01/17/2026

🛡️ PrEP works—but only when patients can access it and feel supported.

This recorded CME symposium equips clinicians with tools to expand equitable HIV prevention and confidently initiate PrEP.
🔗 https://cmeo.me/MMV-156

Pre-exposure prophylaxis (PrEP) is an established and highly effective method of preventing sexually transmitted human immunodeficiency virus (HIV) infections and has been instrumental in declining incidence rates. Adherence and access to HIV prevention still pose challenges...

01/16/2026

🙌 Thank you for participating in our recent activity:
The Changing Face of Primary Immunodeficiency: Improving Diagnosis and Access to Treatment for All Patients

Here are key takeaways to put into action and share with colleagues:
👉 View the activity: https://cmeo.me/SN-287

🔹 Support newborn screening for PI and counsel families on guideline-recommended testing and follow-up
🔹 Recognize typical and atypical PI presentations in children and adults
🔹 Follow diagnostic pathways to confirm PI
🔹 Use shared decision-making (SDM) to align treatment with patient/caregiver preferences and access
🔹 Compare IgRT options (IVIG, SCIG, fSCIG) to individualize care and improve outcomes

Patients living with primary immunodeficiency (PI) disorders face prolonged or severe infections that pose significant challenges to daily life. While infectious PI phenotypes have garnered the most visibility, this focus has left noninfectious variants underrecognized and...

01/16/2026

🙌 Thank you for participating in our activity:
2025 Conference Coverage – In Our Dreams: Improving the Health of Patients Living with IH and Narcolepsy by Connecting with Their Hearts and Heads

Help extend the impact—share this activity with your colleagues today!
👉 https://cmeo.me/JC-033

Put learning into action (next 3 months):
🔹 Assess biopsychosocial pain factors at the first visit
🔹 Use validated tools for opioid risk stratification and pain assessment
🔹 Set patient-centered goals focused on pain relief and function
🔹 Apply the 2022 CDC opioid prescribing guidelines
🔹 Provide multimodal pain management and counseling

When adopting a comprehensive approach to improving the health of patients with idiopathic hypersomnia (IH) or narcolepsy, it is essential for clinicians to consider the interplay between cardiometabolic (CM), neurologic, and psychiatric comorbidities. Clinicians must prioritize...

01/16/2026

👥 Patients with LGS need care that evolves with them.

This CME equips you with insights on:
✅ Early diagnosis
✅ Quality of life optimization
✅ Lifelong care coordination

Watch on demand: https://cmeo.me/MMV146AANN

Lennox-Gastaut syndrome (LGS) remains a challenging condition to understand, diagnose, and manage. Neuroscience/neurology clinicians, including nurses and nurse practitioners (NPs), encounter significant challenges in the management of patients with LGS, due to the severe symptoms and...

01/16/2026

01/15/2026

It’s time to move beyond one-size-fits-all diabetes care.
Explore how to individualize GLP-1 RA therapy for patients with multimorbid conditions in this fast, focused CME activity.
🎯 30 minutes. Practical insights. Immediate impact.
🔗 https://cmeo.me/SN-271

GLP-1 receptor agonists (GLP-1 RAs) are a top-tier recommendation for patients with type 2 diabetes (T2D), especially those with concomitant cardiovascular disease (CVD), chronic kidney disease (CKD), or obesity. Backed by robust clinical trial data and...

01/15/2026

Family medicine providers: You're often the first—and sometimes only—point of care for patients living with HIV.

This CME Outfitters program gives you the tools to close gaps in access, communication, and continuity of care.
📲 https://cmeo.me/AAFPV-003

New diagnoses of HIV continue at a rapid pace despite the availability of preventative options. This is particularly true among underserved populations, including racial and ethnic minorities, who often go undiagnosed or underdiagnosed due to disparities...